|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���ǻ�֢ |
|
�ǻ���ȫ |
|
Ƥ���Լ��� |
| ��������������� | |
|
��� |
|
���ƹ� |
|
½��Ҷ���� |
|
�ļһ���У |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
|
Article by |
���ǻ�֢���о��½�չ
���, ���ƹ�, ½��Ҷ����, �ļһ���У
���ϴ�ѧ�й�ҽѧ�Ŵ�ѧ�����ص�ʵ����
���ǻ�֢��һ���ټ�������Ƥ����,���������ή����Ե��״������Χ�Ƶ�Ƥ��Ϊ����,��������״ζ�λ��������dz���Թ⻯�Ժ��ǻ�֢����
[2] Schamroth JM,Zlotogorski A,Gilead L.Porokeratosis of Mibelli.Overview and review of the literature.Acta Derm Venereol,1997,77(3):207-213.
[3] Jang KA,Choi JH,Sung K J,et al.The hyperkeratotic variant of disseminated superficial actinic porokeratosis (DSAP).Int J Dermatol,1999,38(3):204-206.
[4] Watanabe T,Muakami T,Okochi H,et al.Ulcerative porokeratosis.Dermatology,1998,196(2):256-259.
[5] Flanagan N,Boyadjiev SA,Harper J,et al.Familial craniosynostosis,anal anomalies,and porokeralosis:CAP syndrome.J Med Genet,1998,35(9):763-766.
[6] Magee JW,McCalmont TH,LeBoit PE.Overexpression of p53 tumor suppressor protein in porokeratosis.Arch Dermatol,1994,130(2):187-190.
[7] Urano Y,Susaki S,Ninomiya Y,et al.Immunohistochemical detection of P53 tumor suppressor protein in porokeratosis.J Dermatol,1996,23 (5):365-368.
[8] Ninomiya Y,Urano Y,Yoshimoto K,et al.P53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma.J Dermatol Sci,1997,14(3):173-178.
[9] Xia JH,Yang YF,Deng H,et al.Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1.J Invest Dermatol,2000,11:(6):1071-1074.
[10] Mizukawa Y,Shiohara T.Porokeratosis in patients with hepatitis C virus infection:does hepatitis C vixus infection provide a link between porokeratosis and immunosuppression? Br J Dermatol,1999,141 (1):163-164.
[11] Kawakami T,Saito D,Takahashi K.Overexpression of p21waf/cip1 immunohistochemical staining in Bowen's disease,but not in disseminated superficial porokeratosis.Br J Dermatol,1999,141(4):647-651.
[12] Quinn AG.p21watYcip1 and p53 expression in the skin-intertwined but not inseparable.Br J Dermatol,1999,141(4):613-616.
[13] Nelson C,Cowper S,Morgan M.p53,mdm-2,and p21 waf-1 in the pokeokeratoses.Am J Dermatopathol,1999,21(5):420-425.
[14] Happle R.Cancer proneness of linear porokeratosis may be explanned by allelic loss.Dermatology,1997,195(1):20-25.